Share Price and Basic Stock Data
Last Updated: January 15, 2026, 3:21 am
| PEG Ratio | -0.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mohini Health & Hygiene Ltd operates in the Medical Equipment & Accessories sector, focusing on providing innovative health solutions. The company’s reported sales for the fiscal year ending March 2025 stood at ₹168 Cr, reflecting a decline compared to ₹200 Cr in March 2024. This decline follows a significant growth trajectory, as sales had previously increased from ₹127 Cr in March 2022. Quarterly results indicate a positive trend in the latest periods, with sales reaching ₹101 Cr in September 2023, up from ₹93 Cr in March 2023. The company has seen fluctuations in sales performance, with a notable peak of ₹99 Cr in September 2022, suggesting potential seasonal trends or market dynamics impacting revenue. Over the years, Mohini has managed to increase its sales from ₹49 Cr in March 2014, showcasing a compound annual growth rate (CAGR) indicative of the growing demand in the healthcare sector. However, the recent decrease in revenue raises questions about sustainability and market positioning.
Profitability and Efficiency Metrics
The profitability metrics for Mohini Health & Hygiene Ltd indicate a challenging environment, as evidenced by an operating profit margin (OPM) of -3% for the current period. The operating profit has been inconsistent, with a recorded ₹12 Cr in March 2016 reducing to ₹12 Cr in March 2025. The net profit also faced adversities, reporting a loss of ₹4 Cr in September 2025, highlighting the company’s struggles to maintain profitability amidst rising expenses. The interest coverage ratio (ICR) stood at 7.20x, showcasing a reasonable ability to cover interest obligations despite the profit challenges. The company’s return on equity (ROE) is at 10.0%, which, while positive, is below the typical sector benchmark for high-performing medical equipment firms. Efficiency ratios reveal a cash conversion cycle of 127 days, indicating a slower turnover in working capital compared to the industry average, which could be a focal point for operational improvements.
Balance Sheet Strength and Financial Ratios
Mohini Health & Hygiene Ltd’s balance sheet reflects a relatively stable financial position with total borrowings of ₹37 Cr against reserves of ₹83 Cr, leading to a debt-to-equity ratio of 0.32x. This low leverage suggests a conservative approach to financing, which is generally favorable in the current economic climate. The company reported a book value per share of ₹57.76 as of March 2025, an increase from ₹55.05 in March 2024, indicating gradual strengthening of shareholder equity. Furthermore, the current ratio is at 2.08x, indicating a robust liquidity position, which is crucial for meeting short-term obligations. However, the operating profit margin remains low, and the total assets increased to ₹168 Cr, suggesting that while the company is expanding its asset base, it needs to translate this growth into higher profitability to enhance shareholder value. The price-to-book value (P/BV) ratio of 1.04x indicates that the market values the company slightly above its book value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mohini Health & Hygiene Ltd reveals a strong promoter stake of 64.02%, which is a positive indicator of management’s confidence in the company’s prospects. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) raises concerns about broader market confidence, with the public holding at 34.96%. The total number of shareholders has shown fluctuations, with 737 shareholders reported as of March 2025, down from 749 in September 2024. This decline may reflect investor sentiment amid recent financial performance challenges. The company has not paid dividends in recent years until a modest payout ratio of 8% was reported for March 2024, which could signal a cautious approach to returning capital to shareholders. The lack of dividends in previous years may deter income-focused investors, affecting overall market perception and confidence in the stock.
Outlook, Risks, and Final Insight
Looking ahead, Mohini Health & Hygiene Ltd faces both opportunities and challenges. The company must address its profitability issues to improve its competitive positioning in the medical equipment sector. Risks include the potential for continued revenue declines if market conditions do not improve and the need to manage operational expenses effectively. The high cash conversion cycle indicates inefficiencies that could hinder cash flow and operational flexibility. Strengths include a solid promoter holding and a conservative balance sheet, which provide a buffer against market volatility. The healthcare industry is poised for growth, and if Mohini can leverage its strengths and improve operational efficiencies, it may enhance its market position. Strategic initiatives focusing on cost management and revenue growth could pave the way for recovery, but the company must navigate its current challenges carefully to regain investor confidence and drive long-term value creation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Constronics Infra Ltd | 68.2 Cr. | 54.4 | 120/46.0 | 15.5 | 32.8 | 0.00 % | 19.7 % | 15.8 % | 10.0 |
| Centenial Surgical Suture Ltd | 34.0 Cr. | 93.2 | 189/82.2 | 84.1 | 0.00 % | 3.94 % | 4.64 % | 10.0 | |
| Adeshwar Meditex Ltd | 26.3 Cr. | 18.2 | 25.0/13.3 | 12.7 | 26.1 | 0.00 % | 8.27 % | 5.51 % | 10.0 |
| Poly Medicure Ltd | 16,895 Cr. | 1,667 | 2,938/1,625 | 46.7 | 288 | 0.21 % | 20.1 % | 15.8 % | 5.00 |
| Mohini Health & Hygiene Ltd | 72.6 Cr. | 39.8 | 83.6/36.2 | 21.7 | 55.7 | 0.00 % | 14.1 % | 10.0 % | 10.0 |
| Industry Average | 16,895.00 Cr | 374.52 | 24.15 | 97.34 | 0.04% | 13.22% | 10.35% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 62 | 66 | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 | 76 | 74 |
| Expenses | 54 | 63 | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 | 74 | 76 |
| Operating Profit | 8 | 3 | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 | 3 | -2 |
| OPM % | 13% | 4% | 17% | 7% | 13% | 4% | 5% | 8% | 8% | 6% | 10% | 3% | -3% |
| Other Income | 0 | 6 | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 | 3 | 3 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Profit before tax | 4 | 4 | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 | 2 | -4 |
| Tax % | 5% | 31% | 0% | 3,780% | 25% | 31% | 32% | 46% | 28% | 10% | 30% | 35% | -1% |
| Net Profit | 4 | 3 | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 | 1 | -4 |
| EPS in Rs | 1.99 | 1.48 | 4.10 | -1.01 | 0.90 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 | 0.61 | -2.17 |
Last Updated: December 29, 2025, 11:04 pm
Below is a detailed analysis of the quarterly data for Mohini Health & Hygiene Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 2.00 Cr..
- For Expenses, as of Sep 2025, the value is 76.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to -2.00 Cr., marking a decrease of 5.00 Cr..
- For OPM %, as of Sep 2025, the value is -3.00%. The value appears to be declining and may need further review. It has decreased from 3.00% (Mar 2025) to -3.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to -4.00 Cr., marking a decrease of 6.00 Cr..
- For Tax %, as of Sep 2025, the value is -1.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Mar 2025) to -1.00%, marking a decrease of 36.00%.
- For Net Profit, as of Sep 2025, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to -4.00 Cr., marking a decrease of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.17. The value appears to be declining and may need further review. It has decreased from 0.61 (Mar 2025) to -2.17, marking a decrease of 2.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:58 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 91 | 122 | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 168 | 150 |
| Expenses | 47 | 86 | 112 | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 155 | 150 |
| Operating Profit | 2 | 5 | 10 | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 12 | 0 |
| OPM % | 4% | 5% | 8% | 7% | 12% | 16% | 8% | 12% | 7% | 7% | 7% | 7% | 0% |
| Other Income | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 4 | 6 |
| Interest | 1 | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 4 |
| Depreciation | 0 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 5 |
| Profit before tax | 1 | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 9 | -2 |
| Tax % | 32% | 24% | 10% | 27% | 30% | 26% | 18% | 25% | 29% | 36% | 20% | 31% | |
| Net Profit | 1 | 2 | 4 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 6 | -3 |
| EPS in Rs | 2.88 | 7.62 | 15.03 | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 3.25 | -1.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 100.00% | 50.00% | -16.67% | 60.00% | -25.00% | 0.00% | -16.67% | 40.00% | 57.14% | -45.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | -50.00% | -66.67% | 76.67% | -85.00% | 25.00% | -16.67% | 56.67% | 17.14% | -102.60% |
Mohini Health & Hygiene Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: January 7, 2026, 4:05 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 10 | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 | 83 |
| Borrowings | 23 | 52 | 58 | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 35 | 37 |
| Other Liabilities | 5 | 18 | 11 | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 28 | 36 |
| Total Liabilities | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 | 174 |
| Fixed Assets | 6 | 44 | 42 | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 37 | 37 |
| CWIP | 18 | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 4 |
| Other Assets | 17 | 40 | 44 | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 127 | 133 |
| Total Assets | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 | 174 |
Below is a detailed analysis of the balance sheet data for Mohini Health & Hygiene Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Reserves, as of Sep 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2025) to 83.00 Cr., marking a decrease of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 35.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 8.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 174.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 168.00 Cr. (Mar 2025) to 174.00 Cr., marking an increase of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 37.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 37.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Investments, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 133.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Sep 2025, the value is 174.00 Cr.. The value appears strong and on an upward trend. It has increased from 168.00 Cr. (Mar 2025) to 174.00 Cr., marking an increase of 6.00 Cr..
Notably, the Reserves (83.00 Cr.) exceed the Borrowings (37.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -21.00 | -47.00 | -48.00 | -55.00 | -39.00 | -31.00 | -31.00 | -26.00 | -35.00 | -15.00 | -9.00 | -23.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 133 | 49 | 64 | 89 | 82 | 65 | 60 | 112 | 67 | 72 | 39 |
| Inventory Days | 52 | 15 | 58 | 37 | 44 | 79 | 94 | 126 | 106 | 65 | 55 | 117 |
| Days Payable | 13 | 44 | 14 | 13 | 15 | 16 | 28 | 25 | 18 | 16 | 10 | 29 |
| Cash Conversion Cycle | 65 | 105 | 93 | 88 | 117 | 145 | 131 | 161 | 200 | 116 | 117 | 127 |
| Working Capital Days | 72 | 43 | 24 | 1 | 47 | 66 | 70 | 66 | 110 | 96 | 116 | 120 |
| ROCE % | 8% | 6% | 12% | 13% | 14% | 14% | 10% | 10% | 9% | 12% | 14% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| Diluted EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| Cash EPS (Rs.) | 5.83 | 8.22 | 6.07 | 6.78 | 6.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
| Revenue From Operations / Share (Rs.) | 92.00 | 109.46 | 105.29 | 77.94 | 75.39 |
| PBDIT / Share (Rs.) | 12.50 | 12.00 | 10.44 | 9.59 | 9.90 |
| PBIT / Share (Rs.) | 9.88 | 9.64 | 8.10 | 6.69 | 6.90 |
| PBT / Share (Rs.) | 8.15 | 7.31 | 5.82 | 4.77 | 4.54 |
| Net Profit / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.89 | 3.39 |
| NP After MI And SOA / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| PBDIT Margin (%) | 13.58 | 10.96 | 9.91 | 12.30 | 13.13 |
| PBIT Margin (%) | 10.74 | 8.80 | 7.69 | 8.58 | 9.14 |
| PBT Margin (%) | 8.85 | 6.68 | 5.53 | 6.12 | 6.02 |
| Net Profit Margin (%) | 3.48 | 5.35 | 3.53 | 4.98 | 4.49 |
| NP After MI And SOA Margin (%) | 3.48 | 5.35 | 3.53 | 4.76 | 4.30 |
| Return on Networth / Equity (%) | 5.55 | 10.64 | 7.56 | 8.12 | 7.63 |
| Return on Capital Employeed (%) | 16.10 | 15.83 | 14.35 | 13.05 | 13.42 |
| Return On Assets (%) | 3.48 | 7.65 | 4.90 | 4.30 | 4.03 |
| Long Term Debt / Equity (X) | 0.01 | 0.05 | 0.09 | 0.06 | 0.15 |
| Total Debt / Equity (X) | 0.32 | 0.22 | 0.31 | 0.52 | 0.46 |
| Asset Turnover Ratio (%) | 1.09 | 1.44 | 1.30 | 0.93 | 0.98 |
| Current Ratio (X) | 2.08 | 3.19 | 2.43 | 1.57 | 1.47 |
| Quick Ratio (X) | 1.42 | 2.41 | 1.73 | 1.15 | 0.89 |
| Inventory Turnover Ratio (X) | 5.67 | 6.25 | 5.42 | 3.42 | 3.11 |
| Dividend Payout Ratio (NP) (%) | 15.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 84.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 7.20 | 5.16 | 4.59 | 4.99 | 4.21 |
| Interest Coverage Ratio (Post Tax) (X) | 4.86 | 3.52 | 2.64 | 3.02 | 2.44 |
| Enterprise Value (Cr.) | 129.99 | 113.80 | 119.96 | 93.74 | 79.60 |
| EV / Net Operating Revenue (X) | 0.77 | 0.57 | 0.62 | 0.65 | 0.57 |
| EV / EBITDA (X) | 5.70 | 5.20 | 6.30 | 5.36 | 4.41 |
| MarketCap / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
| Retention Ratios (%) | 84.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.04 | 0.95 | 1.03 | 0.60 | 0.56 |
| Price / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
| EarningsYield | 0.05 | 0.11 | 0.07 | 0.13 | 0.13 |
After reviewing the key financial ratios for Mohini Health & Hygiene Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 8.22 (Mar 24) to 5.83, marking a decrease of 2.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 92.00. It has decreased from 109.46 (Mar 24) to 92.00, marking a decrease of 17.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 12.00 (Mar 24) to 12.50, marking an increase of 0.50.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from 9.64 (Mar 24) to 9.88, marking an increase of 0.24.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 8.15, marking an increase of 0.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For PBDIT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 13.58, marking an increase of 2.62.
- For PBIT Margin (%), as of Mar 25, the value is 10.74. This value is within the healthy range. It has increased from 8.80 (Mar 24) to 10.74, marking an increase of 1.94.
- For PBT Margin (%), as of Mar 25, the value is 8.85. This value is below the healthy minimum of 10. It has increased from 6.68 (Mar 24) to 8.85, marking an increase of 2.17.
- For Net Profit Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 8. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 15. It has decreased from 10.64 (Mar 24) to 5.55, marking a decrease of 5.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.10. This value is within the healthy range. It has increased from 15.83 (Mar 24) to 16.10, marking an increase of 0.27.
- For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 7.65 (Mar 24) to 3.48, marking a decrease of 4.17.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.32, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.44 (Mar 24) to 1.09, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has decreased from 3.19 (Mar 24) to 2.08, marking a decrease of 1.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.67. This value is within the healthy range. It has decreased from 6.25 (Mar 24) to 5.67, marking a decrease of 0.58.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.57. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 15.57, marking an increase of 15.57.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.57. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 8.57, marking an increase of 8.57.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.43. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.43, marking an increase of 84.43.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.43. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 91.43, marking an increase of 91.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.20. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 7.20, marking an increase of 2.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.86. This value is within the healthy range. It has increased from 3.52 (Mar 24) to 4.86, marking an increase of 1.34.
- For Enterprise Value (Cr.), as of Mar 25, the value is 129.99. It has increased from 113.80 (Mar 24) to 129.99, marking an increase of 16.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.77, marking an increase of 0.20.
- For EV / EBITDA (X), as of Mar 25, the value is 5.70. This value is within the healthy range. It has increased from 5.20 (Mar 24) to 5.70, marking an increase of 0.50.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 25, the value is 84.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.42, marking an increase of 84.42.
- For Price / BV (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 1.04, marking an increase of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.05, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mohini Health & Hygiene Ltd:
- Net Profit Margin: 3.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.1% (Industry Average ROCE: 13.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.55% (Industry Average ROE: 10.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.86
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21.7 (Industry average Stock P/E: 24.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Medical Equipment & Accessories | Plot No 109, Sector 3, Dhar Madhya Pradesh 454774 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Avnish Bansal | Managing Director |
| Mr. Viral Patel | Executive Director |
| Mr. Sarvapriya Bansal | Whole Time Director |
| Mrs. Parul Agarwal | Whole Time Director |
| Mr. Mukesh Vyas | Ind. Non-Executive Director |
| Mr. Chandrashekhar Bobra | Ind. Non-Executive Director |
| Mr. Mukul Jain | Ind. Non-Executive Director |
| Mr. Mahesh Fogla | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mohini Health & Hygiene Ltd?
Mohini Health & Hygiene Ltd's intrinsic value (as of 15 January 2026) is ₹98.63 which is 147.81% higher the current market price of ₹39.80, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹72.6 Cr. market cap, FY2025-2026 high/low of ₹83.6/36.2, reserves of ₹83 Cr, and liabilities of ₹174 Cr.
What is the Market Cap of Mohini Health & Hygiene Ltd?
The Market Cap of Mohini Health & Hygiene Ltd is 72.6 Cr..
What is the current Stock Price of Mohini Health & Hygiene Ltd as on 15 January 2026?
The current stock price of Mohini Health & Hygiene Ltd as on 15 January 2026 is ₹39.8.
What is the High / Low of Mohini Health & Hygiene Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mohini Health & Hygiene Ltd stocks is ₹83.6/36.2.
What is the Stock P/E of Mohini Health & Hygiene Ltd?
The Stock P/E of Mohini Health & Hygiene Ltd is 21.7.
What is the Book Value of Mohini Health & Hygiene Ltd?
The Book Value of Mohini Health & Hygiene Ltd is 55.7.
What is the Dividend Yield of Mohini Health & Hygiene Ltd?
The Dividend Yield of Mohini Health & Hygiene Ltd is 0.00 %.
What is the ROCE of Mohini Health & Hygiene Ltd?
The ROCE of Mohini Health & Hygiene Ltd is 14.1 %.
What is the ROE of Mohini Health & Hygiene Ltd?
The ROE of Mohini Health & Hygiene Ltd is 10.0 %.
What is the Face Value of Mohini Health & Hygiene Ltd?
The Face Value of Mohini Health & Hygiene Ltd is 10.0.